Skip to content
10-Q

Quarterly Report

ALBIREO PHARMA, INC.

0001558370-22-016893

← back to feed
Filed
Nov 8, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 1, 2022 20.7M sh
Shares Diluted Q3 2022 · Sep 30, 2022 19.66M sh
Shares Diluted Q3 2022 · Sep 30, 2022 19.54M sh
Shares Diluted Q3 2022 · Sep 30, 2021 19.65M sh
Shares Diluted Q3 2022 · Sep 30, 2021 19.2M sh
Capex Q3 2022 · Sep 30, 2022 $960K
Capex Q3 2022 · Sep 30, 2021 $465K
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$101.43M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$93.67M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $222.48M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $248.11M
Stockholders Equity Q3 2022 · Sep 30, 2022 $100.07M
Stockholders Equity Q3 2022 · Jun 30, 2022 $113.68M
Stockholders Equity Q3 2022 · Mar 31, 2022 $148.19M
Stockholders Equity Q3 2022 · Dec 31, 2021 $175.61M
Stockholders Equity Q3 2022 · Sep 30, 2021 $181.72M
Stockholders Equity Q3 2022 · Jun 30, 2021 $113.5M
Stockholders Equity Q3 2022 · Mar 31, 2021 $147.92M
Stockholders Equity Q3 2022 · Dec 31, 2020 $181.23M
Current Liabilities Q3 2022 · Sep 30, 2022 $37.82M
Current Liabilities Q3 2022 · Dec 31, 2021 $45.35M
Total Liabilities Q3 2022 · Sep 30, 2022 $221.15M
Total Liabilities Q3 2022 · Dec 31, 2021 $126.44M
Current Assets Q3 2022 · Sep 30, 2022 $238.84M
Current Assets Q3 2022 · Dec 31, 2021 $268.93M
Total Assets Q3 2022 · Sep 30, 2022 $321.22M
Total Assets Q3 2022 · Dec 31, 2021 $302.05M
Eps Diluted Q3 2022 · Sep 30, 2022 −$1.92
Eps Diluted Q3 2022 · Sep 30, 2022 −$6.15
Eps Diluted Q3 2022 · Sep 30, 2021 $2.90
Eps Diluted Q3 2022 · Sep 30, 2021 −$1.20
Eps Basic Q3 2022 · Sep 30, 2022 −$1.92
Eps Basic Q3 2022 · Sep 30, 2022 −$6.15
Eps Basic Q3 2022 · Sep 30, 2021 $2.96
Eps Basic Q3 2022 · Sep 30, 2021 −$1.20
Sga Expense Q3 2022 · Sep 30, 2022 $20.56M
Sga Expense Q3 2022 · Sep 30, 2022 $59.02M
Sga Expense Q3 2022 · Sep 30, 2021 $17.61M
Sga Expense Q3 2022 · Sep 30, 2021 $49.83M
Rd Expense Q3 2022 · Sep 30, 2022 $23.31M
Rd Expense Q3 2022 · Sep 30, 2022 $68.1M
Rd Expense Q3 2022 · Sep 30, 2021 $21.08M
Rd Expense Q3 2022 · Sep 30, 2021 $61.92M
Net Income Q3 2022 · Sep 30, 2022 −$37.8M
Net Income Q3 2022 · Sep 30, 2022 −$120.18M
Net Income Q3 2022 · Jun 30, 2022 −$39.95M
Net Income Q3 2022 · Mar 31, 2022 −$42.43M
Net Income Q3 2022 · Sep 30, 2021 $57.09M
Net Income Q3 2022 · Sep 30, 2021 −$23.07M
Net Income Q3 2022 · Jun 30, 2021 −$36.42M
Net Income Q3 2022 · Mar 31, 2021 −$43.73M
Operating Income Q3 2022 · Sep 30, 2022 −$34.66M
Operating Income Q3 2022 · Sep 30, 2022 −$111.42M
Operating Income Q3 2022 · Sep 30, 2021 −$39.18M
Operating Income Q3 2022 · Sep 30, 2021 −$111.99M
Cost Of Revenue Q3 2022 · Sep 30, 2022 $612K
Cost Of Revenue Q3 2022 · Sep 30, 2022 $1.62M
Cost Of Revenue Q3 2022 · Sep 30, 2021 $431K
Cost Of Revenue Q3 2022 · Sep 30, 2021 $431K
Revenue Q3 2022 · Sep 30, 2022 $9.83M
Revenue Q3 2022 · Sep 30, 2022 $24.87M
Revenue Q3 2022 · Sep 30, 2021 $3.66M
Revenue Q3 2022 · Sep 30, 2021 $8.06M
Stock Repurchased Q3 2022 · Sep 30, 2021 $230K